Main Menu

• Home
• About AMS
  • Mission and Vision
  • AMS Executive and Council
  • Education and Research Sub Committee
  • Education and Research Fund
  • AMS Congress 2009
  • AMS Congress 2008
  • Membership Application
  • Memorandum of Association
  • New AMS Website
  • Document on Conflict of Interest
  • Accreditation
    • HON Affiliation
  • Code of Ethics
  • Privacy Statement
• Education
  • Book Reviews
    • Life Begins at Menopause?
    • The Menopause: What you need to know
    • Everybody's Bones
    • Menopause a New Zealand Guide
    • Menopause for Dummies
  • Cochrane Reviews
    • Antifibrinolytics for heavy menstrual bleeding
    • Cyclical progestogens for heavy menstrual bleeding
    • Exercise for vasomotor symptoms
    • Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
    • Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
    • Local oestrogen for vaginal atrophy in postmenopausal women
    • Long term hormone therapy in perimenopausal and postmenopausal women
    • Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
    • Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
    • Oral contraceptive pills for heavy menstrual bleeding
    • Oral contraceptives containing drospirenone for premenstrual syndrome
    • Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
    • Phytoestrogens for vasomotor symptoms
    • Progesterone for premenstrual syndrome
    • Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
    • Selective serotonin reuptake inhibitors for premenstrual syndrome
    • Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
    • Testosterone for peri- and post-menopausal women
  • Information Sheets
    • Bioidentical Hormones for Menopausal Symptoms
    • Contraception For Women Approaching Menopause
    • Coping With Menopause - Depression
    • Diagnosing Menopause
    • Early Menopause due to Chemotherapy
    • Early Menopause Due to Premature and Unexpected Ovarian Failure
    • Healthy Ageing and Lifestyle
    • Low Libido and Testosterone Therapy
    • Menopausal Treatments and the Risk of Blood Clots
    • Menopause and Body Changes
    • Menopause – Combined (Hormone Replacement Therapy)
    • Menopause – Oestrogen Only Therapy
    • Menopause and osteoporosis
    • NonHormonal Treatments for Menopausal Symptoms
    • Sleep Disturbance and the Menopause
    • The AMS Practitioners Guidelines for Oestradiol (E2) Implants
    • The Role of SERMS after Menopause
    • Tibolone For Post-Menopausal Women
    • Treating the Menopause – the Concept of Risk and Benefit
    • WHI Study - Risks and Benefits graphs of HT/HRT
  • Position Statements
    • Estrogen and progestogen use in postmenopausal women: July 2008
    • HRT in the early menopause:
    • IMS updated recommendations on postmenopausal hormone therapy
    • Scientific Definitions for Menopause Related Terminology
  • Resources
    • Presenting a Positive Outlook on the Menopause
    • Menopause Monologues
    • Hormone Replacement Therapy - NHMRC
  • Self Assessment Tools
    • Are you at risk of breast cancer?
    • Are you at risk of cardiovascular disease?
    • Are you at risk of ostoeporotic fracture?
  • Video - Menopause: Evidence-based answers
    • Menopause: Evidence-based answers to your questions
• Find an AMS Doctor
  • New South Wales - City
  • New South Wales - Regional
  • Queensland - City
  • Queensland - Regional
  • Victoria - City
  • Victoria - Regional
  • South Australia - City
  • South Australia - Regional
  • Western Australia - City
  • Western Australia - Regional
  • New Zealand - North Island
  • New Zealand - South Island
  • Tasmania
  • Northern Territory
  • Australian Capital Territory
  • Switzerland
• Health Professionals
  • Book Reviews
    • Life Begins at Menopause?
    • The Menopause: What you need to know
    • Everybody's Bones
    • Menopause a New Zealand Guide
    • Menopause for Dummies
  • Cochrane Reviews
    • Antifibrinolytics for heavy menstrual bleeding
    • Cyclical progestogens for heavy menstrual bleeding
    • Exercise for vasomotor symptoms
    • Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
    • Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
    • Local oestrogen for vaginal atrophy in postmenopausal women
    • Long term hormone therapy in perimenopausal and postmenopausal women
    • Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
    • Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
    • Oral contraceptive pills for heavy menstrual bleeding
    • Oral contraceptives containing drospirenone for premenstrual syndrome
    • Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
    • Phytoestrogens for vasomotor symptoms
    • Progesterone for premenstrual syndrome
    • Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
    • Selective serotonin reuptake inhibitors for premenstrual syndrome
    • Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
    • Testosterone for peri- and post-menopausal women
  • Position Statements
    • Estrogen and progestogen use in postmenopausal women: July 2008
    • HRT in the early menopause:
    • IMS updated recommendations on postmenopausal hormone therapy
    • Scientific Definitions for Menopause Related Terminology
  • Information Sheets
    • Bioidentical Hormones for Menopausal Symptoms
    • Contraception For Women Approaching Menopause
    • Coping With Menopause - Depression
    • Diagnosing Menopause
    • Early Menopause due to Chemotherapy
    • Early Menopause Due to Premature and Unexpected Ovarian Failure
    • Healthy Ageing and Lifestyle
    • Low Libido and Testosterone Therapy
    • Menopausal Treatments and the Risk of Blood Clots
    • Menopause and Body Changes
    • Menopause – Combined (Hormone Replacement Therapy)
    • Menopause – Oestrogen Only Therapy
    • Menopause and osteoporosis
    • NonHormonal Treatments for Menopausal Symptoms
    • Sleep Disturbance and the Menopause
    • The AMS Practitioners Guidelines for Oestradiol (E2) Implants
    • The Role of SERMS after Menopause
    • Tibolone For Post-Menopausal Women
    • Treating the Menopause – the Concept of Risk and Benefit
    • WHI Study - Risks and Benefits graphs of HT/HRT
  • GP & HP Resources
    • The AMS Practitioners Guidelines for Oestradiol (E2) Implants
    • Libido and the Natural Menopause Transition
    • Low Libido: the Psychological Aspect
    • The menopausal transition as a risk factor for sleep apnea in women
    • Biomedical Literature Databases
    • Recommended Journals
    • Rosiglitazone for postmenopausal women with Type 2 diabetes
    • Sleep disturbance during the menopause
    • NHMRC booklet for health professionals
  • Resources
    • Presenting a Positive Outlook on the Menopause
    • Menopause Monologues
    • Hormone Replacement Therapy - NHMRC
  • Self Assessment Tools
    • Are you at risk of breast cancer?
    • Are you at risk of cardiovascular disease?
    • Are you at risk of ostoeporotic fracture?
  • Studies published
    • Testosterone patch and sex drive in women
    • Androgen therapy for loss of desire in women
    • Hormone therapy and risk of myocardial infarction: a national register study
    • LIFT Trial
    • WISDOM Trial
  • Video - Menopause: Evidence-based answers
    • Menopause: Evidence-based answers to your questions
• Members
  • Apply to be a Member
    • Member Update
• Media
  • 2008 Nov 14 - Calcium, vitamin D do not lower breast-cancer risk
  • 2008 Oct 18 - Women take heart – midlife, menopause and beyond
  • 2008 Oct 6 - Hormone therapy and risk of myocardial infarction
  • 2008 Aug 22 - WISDOM Trial published
  • 2008 Aug 26 - LIFT Trial published
  • 2008 Jun 11 - AMS response on HRT and Breast Cancer article
  • 2008 Jan 15 - FDA Takes action against Compounded Menopause Hormone Therapy
  • 2007 June 28 - Use of HRT for menopause related symptoms and disease prevention in apt women
  • 2007 June 22 - AMS MEDIA RELEASE - Estrogen Therapy and Coronary-Artery Calcification
  • 2007 April 24 - NEJM Special Report on Breast Cancer
  • 2007 April 24 - Response to Lancet Paper on Ovarian Cancer in the Million Women Study
  • 2007 April 20 - Breast Cancer Incident and HRT Risk
  • Media Archives
    • 2006 October 17 - World Menopause Day Fact Sheet
    • 2006 October 18 - WORLD MENOPAUSE DAY
    • 2006 September 8 - The "Bioidentical/Bioequivalent" Hormone Scam
    • 2006 August 26 - AMS Congratulates Professor Henry Burger
    • 2006 May 23 - Unopposed Estrogen Therapy and the risk of Invasive Breast Cancer
    • 2006 April 28 - New study results suggest oestrogen alone does not cause breast cancer
    • 2005 September 7 - The risk of breast cancer and postmenopausal Hormone Therapy (HT)
    • 2005 April 30 - Comments by Professor Alastair MacLennan - Million Women Study. Lancet 2005; 365 154
    • 2005 April 30 - Comments by Professor Susan Davis - Million Women Study. Lancet 2005; 365:1543-51
    • 2004 August 17 - Consensus meeting on hormone therapy - comment by Prof Susan Davis
    • 2004 August 17 - HT Consensus Statement
    • 2004 May 14 - Osteoporosis-New Resources for Health Professionals and Women
    • 2004 March 3 - Women's Health initiative oestrogen-only vs placebo study terminated
    • 2003 November 29 - Bioidentical hormones (troches) advice for doctors
    • 2003 November 29 - Bioidentical hormones (troches) advice to consumers
    • 2003 November 29 - Indications for Prescribing Oestrogens and Progestogens in Menopausal Women
    • 2003 November 6 - Hormone Therapy Update
    • 2003 June 25 - WHI Report - The Influence of Estrogen plus Progestin on Breast Cancer and Mammograph
    • 2003 May 29 - WHI report on dementia, cognitive impairment and stroke - initial response
    • 2002 November 20 - The risk of breast cancer with HRT use (AMS statement )
    • 2002 November 1 - A new educational video is available to assist with counselling
    • 2002 October 29 - AMS declines endorsement of New Zealand Guidelines Group
    • 2002 October 29 - AMS declines endorsement of New Zealand Guidelines Group
    • 2002 October 18 - World Menopause Day
    • 2002 July 25 - AMS response to the first report of the Womens Health Initiative
    • 2002 July 16 - Report Expert Committee to the first report of the Women's Health Initiative
    • 2002 July 10 - Initial response to the first report of the Women's Health Initiative
    • 2002 February 14 - The Risk of Breast Cancer With HRT Use
    • 2000 April 7 - HRT and Cardiovascular Disease
    • 2000 March 24 - HRT And Established Heart Disease - implications from the HERS study
    • 2000 February 24 - Australasian Menopause Society reissues warning against misinterpreting new data
    • 2000 January 28 - AMS warns against reports of breast cancer/HRTcausing anxiety in HRTusers

Top Menu

• About our Website
• Apply to be a Member
• Contact Us
• Events
  • 2010 Sep 26-29: Combined Meeting AMS and APMF
  • 2009 Sep 18-20: 13th Annual AMS Congress
  • 2009 Mar 26-30: Annual Scientific Meeting
  • 2009 Mar 14: Annual Women’s Health Update and Education Day – Melbourne
  • 2009 Feb 21: Annual Hormone and Women's Health Update and Education Day, Sydney
• Feedback
• Links
• Site Map